Medtecs International (TPE:9103) EBIT : NT$-678 Mil (TTM As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Medtecs International EBIT?

Medtecs International's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2023 was NT$-512 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-678 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Medtecs International's annualized ROC % for the quarter that ended in Dec. 2023 was -26.81%. Medtecs International's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -26.98%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Medtecs International's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -32.95%.

Medtecs International EBIT Historical Data

The historical data trend for Medtecs International's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medtecs International EBIT Chart

Medtecs International Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

115.11

3,851.84

493.11

-914.51

-680.44

Medtecs International Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT	Get a 7-Day Free Trial															-38.85	-114.27	-796.20	-165.92	-512.31

Competitive Comparison of Medtecs International's EBIT

For the Medical Instruments & Supplies subindustry, Medtecs International's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medtecs International's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medtecs International's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Medtecs International's EV-to-EBIT falls into.

Medtecs International EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-678 Mil.

Medtecs International (TPE:9103) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Medtecs International's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	-1159.118 * ( 1 - 0.29% )	/	( (4287.353	+	4335.208)	/ 2 )
=	-1155.7565578	/	4311.2805
=	-26.81 %

where

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	5604.644	-	278.49	-	( 1038.801	-	max(0, 932.092	-	3419.286	+	1038.801	))
=	4287.353

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	5211.719	-	179.446	-	( 697.065	-	max(0, 1030.299	-	2993.737	+	697.065	))
=	4335.208

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Medtecs International's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-1024.612	/	( ( (1781.131 + max(2101.996, 0))	+	(1674.768 + max(2037.097, 0)) )	/	2 )
=	-1024.612	/	( ( 3883.127	+	3711.865 )	/	2 )
=	-1024.612	/	3797.496
=	-26.98 %

where Working Capital is:

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(886.356	+	1218.847	+	275.282)	-	(278.49	+	0	+	-0.00099999999997635)
=	2101.996

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(627.655	+	1167.525	+	501.492)	-	(179.446	+	0	+	80.129)
=	2037.097

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Medtecs International's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	-678.228	/	2058.119
	=	-32.95 %

Medtecs International EBIT Related Terms

Thank you for viewing the detailed overview of Medtecs International's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Medtecs International (TPE:9103) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medtecs International Corp Ltd (TPE:9103) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

546:Singapore

Address

No. 330 Sen. Gil J. Puyat Avenue, 22nd Floor, The World Centre, Makati, PHL, 1227

Website

https://www.medtecs.com

Medtecs International Corp Ltd is an investment holding company. The company along with its subsidiaries is a manufacturer of medical consumables and provides healthcare products and services. It operates in three segments The Manufacturing segment produces and sub-contracts medical consumables, including patients apparels, disposable surgical masks, boot covers and surgical gowns, adult diapers, underpads, crochet blankets, bed linens and medical bandages. The Hospital services segment provides laundry and leasing services. The Distribution segment is involved in the marketing of Medtecs-branded medical consumables to hospitals, pharmacies, and other end users. It generates the highest revenue from the Manufacturing segment.

Medtecs International (TPE:9103) Headlines

No Headlines